What is Blackford Analysis?
Founded in 2010 by Ben Panter, Blackford Analysis has dedicated over a decade to developing and deploying artificial intelligence solutions for the radiology sector. The company functions as a strategic AI partner, offering a robust core platform, customized services, and a suite of applications designed to enhance diagnostic confidence, improve patient outcomes, and drive operational efficiencies for healthcare providers. Their initial product, focused on improving the assessment of changes in MRI and CT scans, has achieved widespread adoption, being utilized in over 1,000 hospitals and imaging centers, primarily across the US, Australia, and New Zealand.
How much funding has Blackford Analysis raised?
Blackford Analysis has raised a total of $1.3M across 1 funding round:
Unspecified
$1.3M
Unspecified (2014): $1.3M with participation from Archangel Informal Investment, Scottish Investment Bank, TRI Cap, and Old College Capital
Key Investors in Blackford Analysis
Archangel Informal Investment
Archangel Informal Investment is an investment group focused on providing capital to promising ventures. Their involvement suggests a belief in Blackford Analysis's innovative approach and market potential.
Scottish Investment Bank
The Scottish Investment Bank, part of Scottish Enterprise, is a national economic development agency supporting businesses in Scotland. Their participation indicates a strategic interest in fostering technological advancement and economic growth within the region.
TRI Cap
TRI Cap (Tweed Renaissance Investors Capital) is a business angel syndicate that invests in growth-oriented companies. Their backing of Blackford Analysis highlights the company's potential for significant expansion and market impact.
What's next for Blackford Analysis?
The recent major strategic investment signals a new phase of growth and development for Blackford Analysis. With a proven track record and a strong foundation in AI for medical imaging, the company is well-positioned to further scale its operations and expand its market reach. This capital infusion is likely to fuel continued innovation in their AI platform, potentially leading to the development of new applications and deeper integration with healthcare systems globally. The focus on strategic partnerships suggests an intent to solidify its role as a key enabler of AI-driven advancements in radiology.
See full Blackford Analysis company page
